Gene search

Sequence information

Select Gene Cds Cds_length GC_content Pep Pep_length
Lal1g0692 ATGGAAAGAATGTATTCATCTCTTATTTTTCTTTTGTTTTGCATTTGTGACATTTCTCTCATTGAGGGTTTTGGCTTTAGTGTAGAACTCATCCATCGTGATTCTCCAAAATCACCATTTTACATTCCCAGTGAAACTCATTTTGAACGAGTAGTTAAATCTATTCGTCGTTCCATCAACCAAGCAAATCATTTCAACAAACCTTCTTTTTCCACAAAAAATATTGAGTCTGATGTGCTTACTAATAGAGGTGATTACCTCATGAGTTACTCGATTGGCACACCGCCAGTCAAAATCTTAGGTATTGCTGATACTGGTAGTGACATTATTTGGTTGCAATGCAAGCCTTGTGTCCCTTGCTCCCCACAAACCTCTCCAATCTTTGACCCTTCAAAATCCACAACATACAAAAACATTCCTTGCACTTCAAATGCATGTCAAACTGTGAGAGATACCAGTTGCTCTTCACAAAGCAGTCAACAAAGTTGTGAATATAGGATTGGCTATGGGGATGGTTCAAAATCCCAAGGGGGTCTTCGTTTGGATACTCTTACTTTTAGTTCCACTCAGGGCTCTACTGTCTCATTTCCTAAAACGGTGATTGGATGTGGAACCAGTAACACTTTAGGTGATCAAGGTCAAGGCTTTGGCATAGTTGGTCTTGGAAATGGACCTGTTTCCCTCATAACTTGTAACACTTTAGGTGATCAAGGTCAAGGCTCTAGCATAGTTGGTCTTGGAAATGGACCTGTTTCCCTCATAACTCAACTTGGTTCTTCAATACAAGGCAAATTTGCCTATTGTTTGGCGCCATCACTATCAGAAACTGACTCCCCAACGAAACTCAACTTTGGAGTTGAAGCTGTAGTTTCTGGTGATGGTATTGTCTCAACTCCATTGTTCTTAGATAAAGTCTTTTACTACCTAACATTAGAAGCGTTCAGTGTTGGAAATAAAAGATTGGAATTTGGAAGCTCTTCCTTTAGTAGTGGAGGATCTGGTAACATCATAATTGATTCTGGTACAACATTGACTCTTTTGCCCAGTGATGTTTACTCTGAGTTAGAATCAACGGTCGCTTCTGAGATAACATTGAATCGTGTTGAAGCCCCTTCACCATCGTTGAGCCTTTGCTACGAAGCCCCATCAGATGGAAATTTGGACGTTCCAGTGATCACAGCACATTTTACTGGTGCAGATGTCAAGGTGAATGCTCTCAACACCTTTTTTCAAGTTAGTGAAGATACTATATGTTTTACTTTTGTCCCAACTAACCAACCCGTTAGCATATATGGAAATTTGGCACAACAAATGTAA 1317 0.3979 MERMYSSLIFLLFCICDISLIEGFGFSVELIHRDSPKSPFYIPSETHFERVVKSIRRSINQANHFNKPSFSTKNIESDVLTNRGDYLMSYSIGTPPVKILGIADTGSDIIWLQCKPCVPCSPQTSPIFDPSKSTTYKNIPCTSNACQTVRDTSCSSQSSQQSCEYRIGYGDGSKSQGGLRLDTLTFSSTQGSTVSFPKTVIGCGTSNTLGDQGQGFGIVGLGNGPVSLITCNTLGDQGQGSSIVGLGNGPVSLITQLGSSIQGKFAYCLAPSLSETDSPTKLNFGVEAVVSGDGIVSTPLFLDKVFYYLTLEAFSVGNKRLEFGSSSFSSGGSGNIIIDSGTTLTLLPSDVYSELESTVASEITLNRVEAPSPSLSLCYEAPSDGNLDVPVITAHFTGADVKVNALNTFFQVSEDTICFTFVPTNQPVSIYGNLAQQM 438
       

Annotation information

Select Seq ID Length Analysis Description Start End IPR GO
Lal1g0692 438 Pfam Xylanase inhibitor C-terminal 307 437 IPR032799 -
Lal1g0692 438 Gene3D Acid Proteases 60 234 IPR021109 -
Lal1g0692 438 Gene3D Acid Proteases 284 438 IPR021109 -
Lal1g0692 438 Pfam Xylanase inhibitor N-terminal 86 230 IPR032861 -
Lal1g0692 438 Pfam Xylanase inhibitor N-terminal 240 285 IPR032861 -
Lal1g0692 438 ProSitePatterns Eukaryotic and viral aspartyl proteases active site. 336 347 IPR001969 GO:0004190|GO:0006508
Lal1g0692 438 PANTHER OS07G0603500 PROTEIN-RELATED 1 230 - -
Lal1g0692 438 PANTHER OS07G0603500 PROTEIN-RELATED 237 437 - -
Lal1g0692 438 Gene3D Acid Proteases 235 283 IPR021109 -
Lal1g0692 438 CDD pepsin_A_like_plant 86 437 IPR034161 -
Lal1g0692 438 ProSiteProfiles Peptidase family A1 domain profile. 86 438 IPR033121 -
Lal1g0692 438 PANTHER ASPARTIC PROTEINASE CDR1-RELATED 237 437 - -
Lal1g0692 438 PANTHER ASPARTIC PROTEINASE CDR1-RELATED 1 230 - -
Lal1g0692 438 SUPERFAMILY Acid proteases 4 437 IPR021109 -
       

Duplication type information

Select Gene Chromosome Start End Duplicated_type
Lal1g0692 Lal-Chr1 4570399 4573065 Dispersed/Wgd
       

Functional genes information

Select Gene Gene_start Gene_end Function Ath_gene Identity(%) E-value Score
Lal1g0692 84 230 Miscellaneous Gene Families AT1G77480 31.818 8.09e-13 68.2
       

Pathway information

Select Query KO Definition Second KO KEGG Genes ID GHOSTX Score
Lal1g0692 - - gmx:100789696 447.588
       

Event-related genes

Select Gene_1 Chr_1 Start_1 End_1 Gene_2 Chr_2 Start_2 End_2 Event_name
Lal1g0692 1 4570399 4573065 Lal9g0670 9 4613633 4614916 LSH